20 Biomaterials Nanoarchitectonics
[10] L.C. Scott, J.C. Yao, A.B. Benson III, A.L. Thomas, S. Falk, R.R. Mena, J. Picus, J. Wright, M.F. Mulcahy,
J.A. Ajani, T.R. Evans, Cancer Chemother. Pharmacol. 63 (2009) 363.
[11] F.M. Veronese, O. Schiavon, G. Pasut, R. Mendichi, L. Andersson, A. Tsirk, J. Ford, G. Wu, S. Kneller,
J. Davies, R. Duncan, Bioconjug. Chem. 16 (2005) 775.
[12] G. Pasut, F.M. Veronese, Prog. Polym. Sci. 32 (2007) 933.
[13] E.M. Kopecky, S. Greinstetter, I. Pabinger, A. Buchacher, J. Romisch, A. Jungbauer, Biotechnol.
Bioeng. 93 (2006) 647.
[14] K.W. Woodburn, C.P. Holmes, S.D. Wilson, K.L. Fong, R.J. Press, Y. Moriya, Y. Tagawa, Xenobiotica 42
(2012) 660–670.
[15] U.K. Narta, S.S. Kanwar, W. Azmi, Crit. Rev. Oncol. Hematol. 61 (2007) 208.
[16] C.M. Ensor, F.M. Holtsberg, J.S. Bomalaski, M.A. Clark, Cancer Res. 62 (2002) 5443.
[17] F.W. Holtsberg, C.M. Ensor, M.R. Steiner, J.S. Bomalaski, M.A. Clark, J. Control. Release 80 (2002) 259.
[18] P.N. Cheng, T. Lam, W. Lam, S. Tsui, A.W. Cheng, W. Lo, Y. Leung, Cancer Res. 67 (2007) 309.
[19] Y.S. Wang, S. Youngster, M. Grace, J. Bausch, R. Bordens, D.F. Wyss, Adv. Drug Deliv. Rev. 54 (2002)
547.
[20] X.Q. Li, J.D. Lei, A.G. Su, G.H. Ma, Process Biochem. 42 (2007) 1625.
[21] K. Yang, A. Basu, M. Wang, R. Chintala, M.C. Hsieh, S. Liu, J. Hua, Z. Zhang, J. Zhou, M. Li, H. Phyu,
G. Petti, M. Mendez, H. Janjua, P. Peng, C. Longley, V. Borowski, M. Mehlig, D. Filpula, Protein Eng.
16 (2003) 761.
[22] A.P. Chapman, Adv. Drug Deliv. Rev. 54 (2002) 531.
[23] E.W. Ng, D.T. Shima, P. Calias, E.T. Cunningham Jr., D.R. Guyer, A.P. Adamis, Nat. Rev. Drug Discov.
5 (2006) 123.
[24] J. Ruckman, L.S. Green, J. Beeson, S. Waugh, W.L. Gillette, D.D. Henninger, L. Claesson-Welsh,
N. Janjic, J. Biol. Chem. 273 (1998) 20556.
[25] H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, J. Control. Release 65 (2000) 271.
[26] Y. Matsumura, Drug Deliv. Sys. 28 (2013) 215.
[27] D. Schmaljohann, Adv. Drug Deliv. Rev. 58 (2006) 1655.
[28] C.L. Lo, C.K. Huang, K.M. Lin, G.H. Hsiue, Biomaterials 28 (2007) 1225.
[29] Y. Kakizawa, K. Kataoka, Adv. Drug Deliv. Rev. 54 (2002) 203.
[30] S. Fukushima, K. Miyata, N. Nishiyama, N. Kanayama, Y. Yamasaki, K. Kataoka, J. Am. Chem. Soc.
127 (2005) 2810.
[31] M. Oishi, Y. Nagasaki, K. Itaka, N. Nishiyama, K. Kataoka, J. Am. Chem. Soc. 127 (2005) 1624.
[32] S. Guragain, B.P. Bastakoti, S. Yusa, K. Nakashima, Polymer 51 (2010) 3181.
[33] M. Ahmed, Z. Deng, R. Narain, ACS Appl. Mater. Interfaces 9 (2009) 1980.
[34] J. Leleux, R. Krishnendu, Adv. Healthc. Mater. 2 (2013) 72.
[35] T. Yoshitomi, Y. Nagasaki, Adv. Healthc. Mater. 3 (2014) 1149.
[36] K. Kataokaa, A. Haradaa, Y. Nagasaki, Adv. Drug Deliv. Rev. 47 (2001) 113.
[37] G.S. Kwon, T. Okano, Adv. Drug Deliv. Rev. 21 (1996) 107.
[38] S. Chen, S.-X. Cheng, R.-X. Zhuo, Macromol. Biosci. 11 (2011) 576.
[39] M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, J. Control. Release 32 (1994) 269.
[40] M. Yokoyama, S. Fukushima, R. Uehara, K. Okamoto, K. Kataoka, Y. Sakurai, T. Okano, J. Control.
Release 50 (1998) 79.